Search

Theravance Biopharma Inc

Затворен

16.98 -0.18

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

17

Максимум

17.01

Ключови измерители

By Trading Economics

Приходи

-965K

-5.9M

Продажби

3M

21M

P/E

Средно за сектора

16.269

57.371

EPS

0.07

Марж на печалбата

-28.45

Служители

90

EBITDA

5.9M

839K

Препоръки

By TipRanks

Препоръки

Неутрален

12-месечна прогноза

-0.06% downside

Дивиденти

By Acuity

Следващи печалби

9.11.2026 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

4.1M

878M

Предишно отваряне

17.16

Предишно затваряне

16.98

Theravance Biopharma Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

23.08.2026 г., 23:51 ч. UTC

Bitcoin and Ethereum rise amid broader financial trends, while concerns over U.S. national debt and rising bond yields prompt Treasury interventions ahead of key economic data releases.

23.08.2026 г., 23:51 ч. UTC

Bitcoin and Ethereum rise amid concerns over U.S. national debt and bond market pressures, while Asian stocks anticipate recovery following positive U.S. market performance.

23.08.2026 г., 23:51 ч. UTC

Bitcoin and Ethereum rise as U.S. national debt hits $40 trillion, prompting concerns over economic stability and upcoming key economic data releases.

23.08.2026 г., 23:51 ч. UTC

Cryptocurrency prices rise amid U.S. national debt concerns and bond market volatility, as investors brace for major earnings reports and geopolitical tensions.

23.08.2026 г., 23:51 ч. UTC

Australia's Construction Output Expected to Rise 0.4% Amid Cautious Investor Sentiment Ahead of August Release

23.08.2026 г., 23:51 ч. UTC

Australia's RBA Trimmed Mean CPI Release on August 26, 2026, Expected to Reveal Key Insights into Core Inflation Trends Amid Global Economic Uncertainty.

23.08.2026 г., 23:51 ч. UTC

Australia's Inflation Rate Expected to Drop Slightly to 3.2% Amid Economic Shifts and Market Volatility Concerns

23.08.2026 г., 23:51 ч. UTC

Macro News

Bitcoin is higher today, continuing its upward trend since Saturday. Positive sentiment follows Wall Street's rebound amid declining interest rates and rising gold prices.

23.08.2026 г., 23:51 ч. UTC

Japan's Industrial Production Data Release on August 30 Expected to Show Continued Growth Amid Market Concerns.

23.08.2026 г., 23:51 ч. UTC

Japan's Retail Sales YoY Data Release on August 30 Expected to Show Significant Rebound Amid Mixed Economic Sentiment and Recent Stock Market Decline.

23.08.2026 г., 23:41 ч. UTC

Canada's Monthly GDP Growth Expected Amid Trade Tensions and Inflation Concerns Ahead of August 28 Release.

23.08.2026 г., 23:41 ч. UTC

Bank of Korea's Upcoming Interest Rate Decision Sparks Optimism Amid KOSPI Rally and Global Economic Trends

23.08.2026 г., 23:41 ч. UTC

Canada's GDP Growth Rate Faces Caution Amid Escalating U.S. Trade Tensions and Tariff Concerns Ahead of August 28 Release

23.08.2026 г., 23:41 ч. UTC

Canada's Q2 2026 GDP Growth Rate Release Amidst U.S. Trade Tensions and Infrastructure Boosts Scheduled for August 28, Heightening Market Scrutiny.

23.08.2026 г., 23:31 ч. UTC

RBA Bulletin Release on August 27, 2026 Sparks Anticipation Amid Global Decline in Interest Rates and Market Fluctuations.

23.08.2026 г., 23:21 ч. UTC

Upcoming U.S. Retail Inventories Ex Autos Data Release on August 27, 2026, Amid Mixed Sentiment and Economic Growth Concerns

23.08.2026 г., 23:21 ч. UTC

U.S. Goods Trade Balance Expected to Hit $99 Billion Deficit Amid Rising U.S.-Canada Tariff Tensions

23.08.2026 г., 23:21 ч. UTC

U.S. Wholesale Inventories Expected to Rise 0.1% in July Amid Mixed Market Sentiment Ahead of August Release

23.08.2026 г., 23:21 ч. UTC

Canada's Current Account Deficit Expected to Reach -5.5 Billion CAD in Q2 2026 Amid Trade Tensions with U.S.

23.08.2026 г., 23:21 ч. UTC

The CAD/CHF currency pair is lower during after-market hours, reflecting a decline since Friday's close amid notable fluctuations in its one-month trading range.

23.08.2026 г., 23:21 ч. UTC

Correlated Moves

XRP is rising during Sunday’s session, supported by Bitcoin's upward movement. The asset has gained significantly since Saturday and remains above its 20-day moving average.

23.08.2026 г., 23:11 ч. UTC

EUR/NZD is trading higher in after-market hours, continuing a gradual increase since Friday's close, despite a recent trend of lower closes.

23.08.2026 г., 23:11 ч. UTC

U.S. Home Prices Expected to Rise 1.7% YoY Amid Inflation and Economic Uncertainty, According to S&P/Case-Shiller Index

23.08.2026 г., 23:11 ч. UTC

U.S. GDP Price Index QoQ 2nd Estimate Set for August 26, Forecasting a 0.063% Increase Amid Inflation Concerns and Mixed Market Sentiment

23.08.2026 г., 23:11 ч. UTC

South Africa's Trade Balance Data Release on August 28 Expected Amid Fluctuating Trends and Commodity Market Sentiment.

23.08.2026 г., 23:01 ч. UTC

Correlated Moves

Gold/Silver is trading lower, influenced by broader market sentiment and concerns over the U.S. national debt reaching $40 trillion. It remains below its 20-day moving average.

23.08.2026 г., 23:01 ч. UTC

Gold/NZD is trading higher since Friday's close, maintaining a position above its 20-day moving average amid concerns over the U.S. national debt reaching $40 trillion.

23.08.2026 г., 23:01 ч. UTC

Gold/JPY is trading higher, reflecting a broader positive performance. The asset remains significantly above its 20-day moving average, indicating strong underlying momentum.

23.08.2026 г., 23:01 ч. UTC

Gold/HKD is higher today, reflecting a strong trend above its 20-day moving average. Earlier, it reached a high of 2.16% above Friday's close.

23.08.2026 г., 23:01 ч. UTC

Gold/SGD is higher in the current session, maintaining a gain above its 20-day moving average despite a slight pullback from earlier peaks.

Сравнение с други в отрасъла

Ценова промяна

Theravance Biopharma Inc Прогноза

Ценова цел

By TipRanks

-0.06% надолу

12-месечна прогноза

Среден 17 USD  -0.06%

Висок 17 USD

Нисък 17 USD

Според 3 анализатори от Wall Street, предложили 12-месечна ценова цел за Theravance Biopharma Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Неутрален

3 ratings

0

Купи

3

Задържане

0

Продай

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Theravance Biopharma Inc

Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States and Europe. It offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist for the treatment of chronic obstructive pulmonary disease (COPD). The company's product includes Ampreloxetine, an investigational norepinephrine reuptake inhibitor that has completed Phase III study for neurogenic orthostatic hypotension; and TRELEGY for the treatment of COPD and asthma. It has licensing and collaboration agreements with Pfizer Inc. for its preclinical skin-selective pan-JAK inhibitor program, as well as Viatris Inc. Theravance Biopharma, Inc. was incorporated in 2013 and is based in South San Francisco, California.
help-icon Live chat